This infographic provides a guide to the core biotechnological foundations driving modern drug development and their ...

The chronic-disease expert has found an audience by debunking the shadowy health claims that are making their way into the US ...

A Chinese biopharmaceutical firm has sealed a global licensing deal valued at up to US$1.44 billion, the second in a week, as ...

Well, 2025 has been a year of reckoning. This story is part of MIT Technology Review’s Hype Correction package, a series that ...

Mainland China's 17 million Alzheimer's patients can, for the first time, pay less out of pocket for a costly drug touted as ...

Researchers have captured the dynamic nature of nuclear pore complexes with AFM, reshaping our understanding of intracellular ...

Chinese fintech giant Ant Group has pressed ahead with its strategic move into the fast-growing healthcare sector with a ...

At his Hong Kong patisserie Mimmo, Domenico Giammarella is blending French techniques with Italian flair. But another Asian ...

Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective treatments. The gap between the scale of the problem and the funding response ...

AQI hit 345 amid frequent garbage burning across several sectors, with officials promising stricter patrolling, fines and ...

Telehealth utilization as measured by telehealth claim lines(1) decreased nationally and in every US census region except the Northeast in September 2025, according to FAIR Health's Monthly Telehealth ...

US President Donald Trump on Monday signed an executive order (EO) designating illicit fentanyl, a powerful synthetic opioid driving the US overdose crisis, as a weapon of mass destruction. The EO ...